stella
beta
A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer — Stella
Recruiting
Back to Locally Advanced Rectal Cancer (LARC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang
View full record on ClinicalTrials.gov